Potential impact of reduced tobacco use on life and health expectancies in Belgium.


Journal

International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 29 06 2019
accepted: 19 11 2019
revised: 30 10 2019
pubmed: 30 11 2019
medline: 8 7 2020
entrez: 30 11 2019
Statut: ppublish

Résumé

We investigated the potential impact of reduced tobacco use scenarios on total life expectancy and health expectancies, i.e., healthy life years and unhealthy life years. Data from the Belgian Health Interview Survey 2013 were used to estimate smoking and disability prevalence. Disability was based on the Global Activity Limitation Indicator. We used DYNAMO-HIA to quantify the impacts of risk factor changes and to compare the "business-as-usual" with alternative scenarios. The "business-as-usual" scenario estimated that in 2028 the 15-year-old men/women would live additional 50/52 years without disability and 14/17 years with disability. The "smoking-free population" scenario added 3.4/2.8 healthy life years and reduced unhealthy life years by 0.79/1.9. Scenarios combining the prevention of smoking initiation with smoking cessation programs are the most effective, yielding the largest increase in healthy life years (1.9/1.7) and the largest decrease in unhealthy life years (- 0.80/- 1.47). Health impact assessment tools provide different scenarios for evidence-informed public health actions. New anti-smoking strategies or stricter enforcement of existing policies potentially gain more healthy life years and reduce unhealthy life years in Belgium.

Identifiants

pubmed: 31781804
doi: 10.1007/s00038-019-01315-z
pii: 10.1007/s00038-019-01315-z
pmc: PMC7049546
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-138

Références

Eur J Cancer Prev. 2008 Nov;17(6):535-44
pubmed: 18941375
Int J Epidemiol. 2001 Jun;30(3):427-32; discussion 433-4
pubmed: 11416056
Arch Public Health. 2018 Jun 28;76:30
pubmed: 29988309
BMC Public Health. 2016 Aug 05;16:734
pubmed: 27495151
Am J Prev Med. 2010 Jan;38(1):78-84
pubmed: 20117561
Eur J Public Health. 2018 Oct 1;28(5):859-863
pubmed: 29901735
Arch Public Health. 2018 May 28;76:25
pubmed: 29881544
Addiction. 2010 Nov;105(11):1984-8
pubmed: 20722633
Arch Intern Med. 2008 Oct 13;168(18):1968-74
pubmed: 18852397
Scand J Public Health. 2014 Jul;42(5):409-16
pubmed: 24812258
Qual Life Res. 2008 Dec;17(10):1217-27
pubmed: 18931942
PLoS One. 2012;7(2):e32363
pubmed: 22384230
Arch Public Health. 2013 Sep 18;71(1):24
pubmed: 24047278
HSMHA Health Rep. 1971 Apr;86(4):347-54
pubmed: 5554262
Demography. 2012 Nov;49(4):1259-83
pubmed: 23055232
BMC Public Health. 2014 Jul 15;14:723
pubmed: 25026981
Lancet. 2008 Dec 20;372(9656):2124-31
pubmed: 19010526
Tob Control. 2001 Sep;10(3):273-8
pubmed: 11544393
J Am Stat Assoc. 2007 Fall;102(480):1199-1211
pubmed: 26279593
BMC Med Res Methodol. 2015 Jan 02;15:1
pubmed: 25555466
Am J Prev Med. 2010 Mar;38(3 Suppl):S364-72
pubmed: 20176309
Arch Public Health. 2012 Oct 22;70(1):23
pubmed: 23088612
BMC Public Health. 2013 Feb 18;13:149
pubmed: 23418994
Am J Epidemiol. 1999 Apr 1;149(7):645-53
pubmed: 10192312
PLoS One. 2012;7(5):e33317
pubmed: 22590491
Bull World Health Organ. 1999;77(2):181-5
pubmed: 10083720
Arch Public Health. 2013 Feb 04;71(1):2
pubmed: 23379576
Stat Med. 2012 Mar 15;31(6):533-43
pubmed: 22139860
Obesity (Silver Spring). 2009 Apr;17(4):783-9
pubmed: 19165165
J Epidemiol Community Health. 1997 Feb;51(1):80-6
pubmed: 9135793
Soc Sci Med. 2012 May;74(9):1402-6
pubmed: 22401648
J Clin Epidemiol. 2010 Aug;63(8):892-9
pubmed: 20171842
Int J Public Health. 2018 Mar;63(2):223-232
pubmed: 29383383
Tob Control. 2019 Jun 21;:
pubmed: 31227649
J Am Geriatr Soc. 2002 Apr;50(4):691-9
pubmed: 11982670

Auteurs

Martina Otavova (M)

Unit of Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, 5000, Odense, Denmark.
Interdisciplinary Center on Population Dynamics, Department of Public Health, University of Southern Denmark, 5000, Odense, Denmark.

Herman Van Oyen (H)

Department of Epidemiology and public health, Sciensano, Rue J Wytsman 14, 1050, Brussels, Belgium.
Department of Public Health and Primary Care, Faculty of Medicine, Ghent University, Ghent, Belgium.

Renata T C Yokota (RTC)

Department of Epidemiology and public health, Sciensano, Rue J Wytsman 14, 1050, Brussels, Belgium.

Rana Charafeddine (R)

Department of Epidemiology and public health, Sciensano, Rue J Wytsman 14, 1050, Brussels, Belgium.

Luk Joossens (L)

Association of European Cancer Leagues, Brussels, Belgium.

Geert Molenberghs (G)

I-BioStat, Universiteit Hasselt & KU Leuven, Hasselt, Belgium.

Wilma J Nusselder (WJ)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Hendriek C Boshuizen (HC)

Department of Statistics, Informatics and Mathematical Modeling, Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Brecht Devleesschauwer (B)

Department of Epidemiology and public health, Sciensano, Rue J Wytsman 14, 1050, Brussels, Belgium. brecht.devleesschauwer@sciensano.be.
Department of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium. brecht.devleesschauwer@sciensano.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH